Showing results (221-230 of 248) with videos related to
Sort By:
Pageof 25
British Journal of Pharmacology|June 9, 2024
Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitisGu-Choul Shin, Hyeong Min Lee, Nayeon Kim, et al.Cancer Research and Treatment|April 22, 2011
Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast CancerMin-Ho Park, Deok-Hwan Yang, Mi-Hyun Kim, et al.Anticancer Research|October 7, 2017
Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells <i>In Vitro</i>Dang-Huan Pham, Ju-Sun Kim, Sang-Ki Kim, et al.Small (Weinheim an Der Bergstrasse, Germany)|September 25, 2024
Efficient Polycrystalline Single-Cation Perovskite Light-Emitting Diodes by Simultaneous Intracrystal and Interfacial Defect PassivationHobeom Kim, Jung-Min Heo, Christoph Wolf, et al.Annals of Surgical Treatment and Research|January 5, 2023
Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society RegistryHannah Lois Kangleon-Tan, Jongmin Sim, Ji Young You, et al.Breast (Edinburgh, Scotland)|September 27, 2020
A nationwide, multicenter retrospective study on the effectiveness and safety of eribulin in Korean breast cancer patients (REMARK)Min Ho Park, Soo Jung Lee, Woo Chul Noh, et al.Nature|October 5, 2012
Probing graphene grain boundaries with optical microscopyDinh Loc Duong, Gang Hee Han, Seung Mi Lee, et al.JAMA Network Open|March 21, 2022
Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Breast Cancer Risk Prediction Among Asian WomenYaohua Yang, Ran Tao, Xiang Shu, et al.International Journal of Surgery (London, England)|November 24, 2023
Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA studySoong June Bae, Hee Jeong Kim, Hyun-Ah Kim, et al.Breast Cancer Research : BCR|November 6, 2024
Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy: an ASTRRA SubstudyYoung Joo Lee, Woo Chul Noh, Sungchan Gwark, et al.Pageof 25